Madrid, Community of Madrid, Spain
+24 years of experience in multinational, family-owned and fund owned companies, 13 of which serving in C-level roles as CHRO, in both people-intensive organizations with up to 10,000 employees and in highly demanding environments competing for scarce technological talent. As CHRO, I have a proven track record in labor relations, collective bargaining and corporate restructuring / recruitment, training and development / organizational and cultural transformation / P&L management / workforce planning / corporate governance and compliance. Additional expertise in executive search, human capital consultancy and leadership advisory for C-suite and Boards. From 2014 to 2021 I have been a lecturer on the Master's Degree in Human Resources Management at AEDIPE, as well as speaker at various forums and institutions, including the “Adolfo Posada Institute of Public Administration”, and “Manuel Giménez Abad" Foundation. Award "Best Business Trajectory 2019" 1st Edition "DIVEM Awards" Socially responsible companies for DIVERSITY management. Author of an analytical article published by the "Spanish Institute for Strategic Studies" (IEEE)
Strategic human capital planning Negotiation Labor relations-colletive bargaining Organizational and cultural transformation
Executive Search & Leadership Consulting: BIOTECH & PHARMA / DEFENSE & AEROSPACE / RETAIL-LOGISTICS
Member of the Steering Comittee and Compliance Board Turnover: +1.600 M€. Employees: +10.000. B.U: + 280 sites.
Reporting to the Chairman of the Board and CEO, I have been member of the steering committee in charge of restructuring, "turnaround" and "exit" the Company (May 2023). President of the Compliance Board Owned by Kartesia Fund until its sale to Wacker Chemie in May 2023, ADL Biopharma is a biotechnology company (CDMO) with two activities: precision fermentation (molecule manufacturing for the food and health care industries) and purification synthesis of oral antibiotics.